EXPLORINEER
en

VN — VnExpress

US Startup Uses AI-Designed Viruses to Treat Disease

AI2 min read

A US startup used phage viruses designed by AI to treat a patient with a serious bacterial infection. This is believed to be the first time AI-designed viruses were used this way.

What happened

Radical Numerics, a US startup, used special viruses made with AI to treat a patient with a serious bacterial infection. The company described the work in a technical report posted on its website on October 20. The company would not share details about the patient or the doctors who ran the test, citing privacy. The company's leader said the test was approved by the US Food and Drug Administration (FDA). The report has not yet been checked by other scientists or published in a science journal.

What are phages?

Phages are viruses that attack only bacteria. They stick to a bacterium, push their genetic material inside, and make many copies of themselves. The bacterium swells up, bursts, and dies. Doctors have used phages for more than a century. Today, they are becoming popular again because many bacteria now resist antibiotics, which are medicines that kill bacteria. Phage treatment is harder to do than taking a pill, because each phage kills only certain types of bacteria. Doctors must test whether a phage works for each patient's infection.

Key facts

  • The AI model Evo 2 was trained on millions of DNA sequences.
  • Evo 2 created about 700,000 virus genomes (complete sets of genetic material).
  • Scientists made DNA from 285 of these genomes and put them into bacteria.
  • 16 of those genomes produced viruses that could survive.

Why it matters

If this works, AI could help doctors create a custom treatment for each patient. This could help fight the toughest drug-resistant bacteria. Phages may also be a new option instead of antibiotics, because they target bacteria very precisely and do not harm other healthy cells in the body.

What to watch

  • Whether the company publishes its findings in a science journal.
  • Whether other scientists can check and repeat the results.
  • Whether the patient's results are shared, which needs permission from the patient or the approving authority.
  • How the company's new AI model, Omnii, is used for other health problems, such as cancer vaccines.

Glossary

Radical Numerics
A US startup company that designs AI-made viruses to treat infections and works on other medical AI projects.
Evo 2
An AI model from the Arc Institute, trained on DNA, that can design new genetic sequences.
Omnii
A new AI model from Radical Numerics that can learn from DNA, proteins, and molecules that control genes.
FDA
The US Food and Drug Administration, the government agency that approves medicines and medical tests.
AIZDNet Korea

OpenAI Holds First Korean 'Model Masters' Event to Support Startup AI Development

OpenAI held its first 'OpenAI Model Masters' event in Korea on the 23rd at its Seoul office, where 11 startups demonstrated services built on its models. The program, which provides API credits to startups recommended by venture capitalists, aims to help turn AI ideas into real products. OpenAI highlighted the selected startup Cutback's video-editing work as a standout example.

AITechCrunch

Grok releases the first seven minutes of its AI-generated ‘Odyssey’

Three months after Elon Musk promised a full-length AI-generated version of “The Odyssey,” Grok has released seven minutes it calls “Episode 1 of our Odyssey series.” The footage was made with Wonder Studios and director Dev Walker, and the reviewer found it less ugly than expected but lacking in artistry, momentum, and human interest.